RT @drdavidliew: Biosimilar multi-switching in RA: is it an issue? Switching back & forth between originator &
Tweet Content
Biosimilar multi-switching in RA: is it an issue?
Switching back & forth between originator & biosimilar should create ideal conditions for immunogenicity or anti-drug Ab
This study: multi-switching vs no switching
No issues at all
Switch away in RA!
ABST1589 #ACR22 @RheumNow https://t.co/pGBF2BHp7y
Show on Archive Page
On
Display in Search Results
On
PDQ
Off